NexturnBioscience Co. Ltd (089140) Fair Value & Analysis
Industrials · KR · Market cap 34.0B KRW
Fair value as of: Aug 13, 2026
From 6 valuation models · updated 6 days ago
Share price +5.8% over the past month.
Below-average quality, and screening another 21% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (1,790 KRW). The favourable scenario is already priced in.
- Weak quality (26/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The models converge in a tight band (1,660 KRW to 1,790 KRW), unusually little disagreement for a valuation.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 1,853 KRW – 56,500 KRW · fair‑value band 1,660 KRW – 1,790 KRW · the 2,275 KRW price screens above the 1,790 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
NexturnBioscience Co. Ltd (089140) currently trades at 2,275 KRW, while our model-based Fair Value estimate is 1,790 KRW, implying the stock looks roughly 21.3% overvalued today. The Quality Score stands at 26/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, NexturnBioscience Co. Ltd generated revenue of 20.5B KRW at a net margin of 9.8%. Revenue grew 237.3% year over year. Net debt stands at 74.5B KRW. Fundamentals as of Aug 13, 2026
Our scenario range runs from 1,660 KRW (bear case) to 1,790 KRW (bull case); at 2,275 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 30% below its 52-week high and 16% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -13% fair-value upside, at -21%, 089140 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 6 models by family
Widest divergence: Asset-Based (6,071 KRW) versus Earnings-Based (2,286 KRW). Highest evidence: ROIC Compounder (72).
Notify me when 089140 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 25 · Market factors (momentum, volatility) 30
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Nexturn Co.,Ltd. develops and produces CNC automatic lathe machines in Korea and internationally. It provides CNC swiss-type automatic lathe products, high temperature display glass press equipment, and automatic line-up robots, as well as an intelligent intervention robot system based on robot 3D cardiovascular visualization technology.
Full company description
Nexturn Co.,Ltd. develops and produces CNC automatic lathe machines in Korea and internationally. It provides CNC swiss-type automatic lathe products, high temperature display glass press equipment, and automatic line-up robots, as well as an intelligent intervention robot system based on robot 3D cardiovascular visualization technology. The company was formerly known as KMT Incorporated and changed its name to Nexturn Co.,Ltd. in April 2004. Nexturn Co.,Ltd. was founded in 2000 and is based in Yongin, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
NexturnBioscience Co. Ltd reported revenue of 70.4B KRW in FY2025 versus 17.0B KRW in FY2021, a compound +42.7%/yr. Reported net income was −9.7B KRW in FY2025.
089140 screens 21% overvalued. Compare with NIBE Industrier AB →
Peer Group
Machinery, Tools, Heavy Vehicles, Trains & Ships · 37 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Machinery, Tools, Heavy Vehicles, Trains & Ships stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| NIBE Industrier AB NIBEB | CHF 3.33 | CHF 2.28 | -32% |
| 505790 505790 | ₹4,044 | ₹8,002 | +98% |
| BHI Co 083650 | 56,500 KRW | 43,356 KRW | -23% |
| VITZROCELL Co 082920 | 34,150 KRW | 23,575 KRW | -31% |
| Sungho Electronics Corp 043260 | 19,930 KRW | 17,261 KRW | -13% |
| SKF India Limited 500472 | ₹1,532 | ₹695.28 | -55% |
| 506076 506076 | ₹2,164 | ₹2,741 | +27% |
| Hyulim ROBOT Co 090710 | 7,720 KRW | 1,053 KRW | -86% |
| Blue Star Limited 500067 | ₹1,510 | ₹3,534 | +134% |
| Tae Kwang Corporation 023160 | 23,200 KRW | 24,471 KRW | +5% |
Compare NexturnBioscience Co. Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is NexturnBioscience Co. Ltd (089140) overvalued or undervalued?
What is the fair value of 089140?
What is the quality score of 089140?
What is the revenue of NexturnBioscience Co. Ltd (089140)?
What is the net profit margin of 089140?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track NexturnBioscience Co. Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.